These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11300102)

  • 21. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.
    Biroccio A; Candiloro A; Mottolese M; Sapora O; Albini A; Zupi G; Del Bufalo D
    FASEB J; 2000 Apr; 14(5):652-60. PubMed ID: 10744622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiogenic response of MCF7 human breast cancer to hormonal treatment: assessment by dynamic GdDTPA-enhanced MRI at high spatial resolution.
    Furman-Haran E; Margalit R; Maretzek AF; Degani H
    J Magn Reson Imaging; 1996; 6(1):195-202. PubMed ID: 8851428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels.
    Lee CN; Cheng WF; Chen CA; Chu JS; Hsieh CY; Hsieh FJ
    Obstet Gynecol; 2000 Oct; 96(4):615-21. PubMed ID: 11004369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [VEGF121 expression and angioneogenesis in lung cancer].
    Ota Y; Shimizu J; Oda M; Hayashi Y; Kure T; Nagatoshi A; Tabata T; Watanabe Y
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):396-8. PubMed ID: 9235356
    [No Abstract]   [Full Text] [Related]  

  • 25. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression.
    Toi M; Inada K; Suzuki H; Tominaga T
    Breast Cancer Res Treat; 1995; 36(2):193-204. PubMed ID: 8534867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
    Bäuerle T; Komljenovic D; Berger MR; Semmler W
    J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.
    Abramovitch R; Dafni H; Smouha E; Benjamin LE; Neeman M
    Cancer Res; 1999 Oct; 59(19):5012-6. PubMed ID: 10519416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
    Clément O; Pradel C; Siauve N; Frouin F; Bruneteau G; Kahn E; Frija G; Cuénod CA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S328-9. PubMed ID: 12188264
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer.
    George ML; Dzik-Jurasz AS; Padhani AR; Brown G; Tait DM; Eccles SA; Swift RI
    Br J Surg; 2001 Dec; 88(12):1628-36. PubMed ID: 11736977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of vascular endothelial growth factor in breast cancer.
    Gasparini G
    Oncologist; 2000; 5 Suppl 1():37-44. PubMed ID: 10804090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
    Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
    Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
    Shimo T; Nakanishi T; Nishida T; Asano M; Sasaki A; Kanyama M; Kuboki T; Matsumura T; Takigawa M
    Oncology; 2001; 61(4):315-22. PubMed ID: 11721179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
    Brasch RC; Gossmann A; Helbich TH; Kuriyama N; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA
    Acad Radiol; 2002 Aug; 9 Suppl 2():S326-7. PubMed ID: 12188263
    [No Abstract]   [Full Text] [Related]  

  • 35. Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
    Hylton NM
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):321-32, vi. PubMed ID: 11493422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
    Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
    Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
    Rofstad EK; Danielsen T
    Br J Cancer; 1998 Mar; 77(6):897-902. PubMed ID: 9528831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis.
    Frouge C; Guinebretière JM; Contesso G; Di Paola R; Bléry M
    Invest Radiol; 1994 Dec; 29(12):1043-9. PubMed ID: 7536719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging.
    Weissleder R; Bogdanov A; Tung CH; Weinmann HJ
    Bioconjug Chem; 2001; 12(2):213-9. PubMed ID: 11312682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.